Trinity Biotech PLC (TRIB)
0.8019
-0.01
(-1.00%)
USD |
NASDAQ |
Dec 27, 16:00
0.8195
+0.02
(+2.19%)
After-Hours: 20:00
Trinity Biotech Cash from Investing (Quarterly): -3.101M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amarin Corp PLC | -56.55M |
| DBV Technologies SA | -0.109M |
| Cellectis SA | 22.33M |
| Adaptimmune Therapeutics PLC | -66.02M |
| Akari Therapeutics PLC | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.623M |
| Cash from Financing (Quarterly) | 4.242M |
| Free Cash Flow | -15.52M |
| Free Cash Flow Per Share (Quarterly) | -0.6085 |
| Free Cash Flow to Equity (Quarterly) | -7.17M |
| Free Cash Flow to Firm (Quarterly) | -4.101M |
| Free Cash Flow Yield | -176.5% |